Compare Asahi Intecc Co., Ltd. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 11.11%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 98.37
3
Healthy long term growth as Net Sales has grown by an annual rate of 19.22%
4
With a growth in Net Sales of 12.76%, the company declared Very Positive results in Dec 25
5
With ROE of 18.24%, it has a very expensive valuation with a 5.39 Price to Book Value
6
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
JPY 879,046 Million (Mid Cap)
30.00
NA
0.00%
-0.29
18.24%
5.57
Revenue and Profits:
Net Sales:
35,208 Million
(Quarterly Results - Dec 2025)
Net Profit:
8,024 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
30.62%
0%
30.62%
6 Months
37.55%
0%
37.55%
1 Year
50.62%
0%
50.62%
2 Years
43.74%
0%
43.74%
3 Years
31.35%
0%
31.35%
4 Years
34.23%
0%
34.23%
5 Years
12.41%
0%
12.41%
Asahi Intecc Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
19.22%
EBIT Growth (5y)
30.15%
EBIT to Interest (avg)
98.37
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.72
Tax Ratio
38.95%
Dividend Payout Ratio
51.64%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.52%
ROE (avg)
11.11%
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
5.39
EV to EBIT
21.72
EV to EBITDA
17.34
EV to Capital Employed
7.18
EV to Sales
6.20
PEG Ratio
0.48
Dividend Yield
NA
ROCE (Latest)
33.06%
ROE (Latest)
18.24%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
35,208.00
36,058.00
-2.36%
Operating Profit (PBDIT) excl Other Income
13,631.00
15,259.00
-10.67%
Interest
39.00
39.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
8,024.00
9,228.00
-13.05%
Operating Profit Margin (Excl OI)
322.00%
361.50%
-3.95%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -2.36% vs 27.82% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -13.05% vs 132.03% in Sep 2025
Annual Results Snapshot (Consolidated) - Jun'25
Jun'25
Jun'24
Change(%)
Net Sales
120,025.00
107,547.00
11.60%
Operating Profit (PBDIT) excl Other Income
40,226.00
31,855.00
26.28%
Interest
214.00
226.00
-5.31%
Exceptional Items
-10,930.00
-199.00
-5,392.46%
Consolidate Net Profit
12,792.00
15,895.00
-19.52%
Operating Profit Margin (Excl OI)
250.60%
205.80%
4.48%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2025 is 11.60% vs 19.36% in Jun 2024
Consolidated Net Profit
YoY Growth in year ended Jun 2025 is -19.52% vs 19.73% in Jun 2024
About Asahi Intecc Co., Ltd. 
Asahi Intecc Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






